Cochrane Abstracts
Risk‐reducing medications for primary breast cancer: a network meta‐analysis New
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Risk‐reducing Medications for Primary Breast Cancer: a Network Meta‐analysis New." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/432430/all/Risk‐reducing_medications_for_primary_breast_cancer:_a_network_meta‐analysis_New. Accessed 05 June 2023.
Risk‐reducing medications for primary breast cancer: a network meta‐analysis New. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/432430/all/Risk‐reducing_medications_for_primary_breast_cancer:_a_network_meta‐analysis_New. Accessed June 5, 2023.
Risk‐reducing medications for primary breast cancer: a network meta‐analysis New. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/432430/all/Risk‐reducing_medications_for_primary_breast_cancer:_a_network_meta‐analysis_New
Risk‐reducing Medications for Primary Breast Cancer: a Network Meta‐analysis New [Internet]. In: Cochrane Abstracts. [cited 2023 June 05]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/432430/all/Risk‐reducing_medications_for_primary_breast_cancer:_a_network_meta‐analysis_New.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Risk‐reducing medications for primary breast cancer: a network meta‐analysis New
ID - 432430
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/432430/all/Risk‐reducing_medications_for_primary_breast_cancer:_a_network_meta‐analysis_New
DB - Evidence Central
DP - Unbound Medicine
ER -
